Observational studyIndian journal of ophthalmology2026
The SKIBI study: Comparative early outcomes of five minimally invasive glaucoma surgeries combined with cataract extraction in Indian patients with primary open-angle glaucoma.
Observational study in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate and compare the early clinical outcomes of five microinvasive glaucoma surgery (MIGS) techniques-Suture-Gonioscopy-Assisted Transluminal Trabeculotomy (Suture-GATT), Kahook Dual Blade (KDB), iStent, Bent Ab Interno Needle Goniectomy (BANG), and iStent inject-combined with phacoemulsification, in a real-world cohort of Indian patients with primary open-angle glaucoma (POAG) and coexisting cataract.
methodsThis prospective observational study included 113 eyes of 113 patients undergoing MIGS with phacoemulsification at a tertiary care center. Patients were allocated to one of five MIGS groups in a nonrandomized fashion through shared decision-making based on clinical profile, affordability considerations, and device availability. The procedures included Suture-GATT (21 eyes), KDB (28 eyes), iStent (20 eyes), BANG (31 eyes), and iStent inject (13 eyes). The intraocular pressure (IOP) and antiglaucoma medication (AGM) use were recorded at baseline and at 1 week, 1 month, 3 months, and 6 months postoperatively. Safety and complications were also assessed.
resultsAll procedures led to significant IOP and AGM reduction at 6 months (P < 0.05). Numerically greater mean IOP reduction was observed in the Suture-GATT group (6.41 ± 2.05 mmHg), with 71% achieving complete success. iStent inject and KDB also showed favorable outcomes. IStent-based procedures had the lowest complication rates.
conclusionIn real-world clinical practice, MIGS combined with cataract surgery offers a safe and effective option for IOP and medication reduction across a range of POAG severities. Procedure selection is influenced by patient-specific factors, including cost and device availability, underscoring the importance of individualized care in resource-variable settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.